Lung Cancer Screening-Trends and Current Studies

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2024 Aug 10

PMID 39123419

Authors

Aleksandra Czerw

Andrzej Deptala

Olga Partyka

Monika Pajewska

Ewa Wisniewska

Katarzyna Sygit

Slawomir Wysocki

Elzbieta Cipora

Magdalena Konieczny

Tomasz Banas

Krzysztof Malecki

Elzbieta Grochans

Szymon Grochans

Anna M Cybulska

Daria Schneider-Matyka

Ewa Bandurska

Weronika Ciecko

Jaroslaw Drobnik

Piotr Pobrotyn

Urszula Grata-Borkowska

Joanna Furtak-Pobrotyn

Aleksandra Sierocka

Michal Marczak

Remigiusz Kozlowski

Affiliations

Soon will be listed here.

Abstract

Lung cancer is the leading cause of death among all the oncological diseases worldwide. This applies to both women and men; however, the incidence and mortality among women is on the rise. In 2020, lung cancer was responsible for 1.8 million deaths (18%). More than 90% of lung cancer cases and 77.1% of lung cancer deaths occur in countries with high and very high HDI (human development index) values. The aim of our study is to the present trends and most recent studies aimed at lung cancer screening. In the face of the persistently high mortality rate, conducting research aimed at extending already-implemented diagnostic algorithms and behavioural interventions focused on smoking cessation is recommended.

References

Yan M, Wang Y, Chen J, Zhou J . Potential of nonporous adaptive crystals for hydrocarbon separation. Chem Soc Rev. 2023; 52(17):6075-6119. DOI: 10.1039/d2cs00856d. View

Subramanian J, Govindan R . Lung cancer in never smokers: a review. J Clin Oncol. 2007; 25(5):561-70. DOI: 10.1200/JCO.2006.06.8015. View

Krist A, Davidson K, Mangione C, Barry M, Cabana M, Caughey A . Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2021; 325(10):962-970. DOI: 10.1001/jama.2021.1117. View

de Koning H, van der Aalst C, de Jong P, Scholten E, Nackaerts K, Heuvelmans M . Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. N Engl J Med. 2020; 382(6):503-513. DOI: 10.1056/NEJMoa1911793. View

Hirales Casillas C, Flores Fernandez J, Padilla Camberos E, Herrera Lopez E, Leal Pacheco G, Martinez Velazquez M . Current status of circulating protein biomarkers to aid the early detection of lung cancer. Future Oncol. 2014; 10(8):1501-13. DOI: 10.2217/fon.14.21. View

Tong F, Zhou Y, Xu Y, Chen Y, Yudintceva N, Shevtsov M . Supramolecular nanomedicines based on host-guest interactions of cyclodextrins. Exploration (Beijing). 2023; 3(4):20210111. PMC: 10624390. DOI: 10.1002/EXP.20210111. View

Juan Tan J, Kong S, Tai J, Poh H, Yao F, Sia Y . Experimental and bioinformatics considerations in cancer application of single cell genomics. Comput Struct Biotechnol J. 2021; 19:343-354. PMC: 7788095. DOI: 10.1016/j.csbj.2020.12.021. View

Siegel D, Fedewa S, Henley S, Pollack L, Jemal A . Proportion of Never Smokers Among Men and Women With Lung Cancer in 7 US States. JAMA Oncol. 2020; 7(2):302-304. PMC: 7716251. DOI: 10.1001/jamaoncol.2020.6362. View

Gray E, Teare M, Stevens J, Archer R . Risk Prediction Models for Lung Cancer: A Systematic Review. Clin Lung Cancer. 2015; 17(2):95-106. DOI: 10.1016/j.cllc.2015.11.007. View

10.

Livingstone-Banks J, Fanshawe T, Thomas K, Theodoulou A, Hajizadeh A, Hartman L . Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2023; 5:CD006103. PMC: 10169257. DOI: 10.1002/14651858.CD006103.pub8. View

11.

Ji X, Bosse Y, Landi M, Gui J, Xiao X, Qian D . Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk. Nat Commun. 2018; 9(1):3221. PMC: 6089967. DOI: 10.1038/s41467-018-05074-y. View

12.

Aberle D, Adams A, Berg C, Black W, Clapp J, Fagerstrom R . Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011; 365(5):395-409. PMC: 4356534. DOI: 10.1056/NEJMoa1102873. View

13.

Wang Y, Zhu H, Zhang L, He J, Bo J, Wang J . Common immunological and prognostic features of lung and bladder cancer via smoking-related genes: PRR11 gene as potential immunotherapeutic target. J Cell Mol Med. 2024; 28(10):e18384. PMC: 11101993. DOI: 10.1111/jcmm.18384. View

14.

Chen J, Zhang W, Yang W, Xi F, He H, Liang M . Separation of benzene and toluene associated with vapochromic behaviors by hybrid[4]arene-based co-crystals. Nat Commun. 2024; 15(1):1260. PMC: 10858960. DOI: 10.1038/s41467-024-45592-6. View

15.

Shiels M, Graubard B, McNeel T, Kahle L, Freedman N . Trends in smoking-attributable and smoking-unrelated lung cancer death rates in the United States, 1991-2018. J Natl Cancer Inst. 2023; 116(5):711-716. PMC: 11077306. DOI: 10.1093/jnci/djad256. View

16.

Shehata S, Toraih E, Ismail E, Hagras A, Elmorsy E, Fawzy M . Vaping, Environmental Toxicants Exposure, and Lung Cancer Risk. Cancers (Basel). 2023; 15(18). PMC: 10526315. DOI: 10.3390/cancers15184525. View

17.

Yan M, Wu S, Wang Y, Liang M, Wang M, Hu W . Recent Progress of Supramolecular Chemotherapy Based on Host-Guest Interactions. Adv Mater. 2023; 36(21):e2304249. DOI: 10.1002/adma.202304249. View

18.

Kim M, Steffensen I, Miguel R, Babic T, Carlone J . A Systematic Review Investigating Associations Between E-Cigarette Use Among Former Cigarette Smokers and Relapse to Smoking Cigarettes. Inquiry. 2023; 60:469580231214457. PMC: 10687958. DOI: 10.1177/00469580231214457. View

19.

Zhu J, Branstetter S, Lazarus P, Muscat J . Smoking, Lung Cancer Stage, and Prognostic Factors-Findings from the National Lung Screening Trial. Int J Environ Res Public Health. 2024; 21(4). PMC: 11050078. DOI: 10.3390/ijerph21040400. View

20.

Li C, Lei S, Ding L, Xu Y, Wu X, Wang H . Global burden and trends of lung cancer incidence and mortality. Chin Med J (Engl). 2023; 136(13):1583-1590. PMC: 10325747. DOI: 10.1097/CM9.0000000000002529. View